Veteran equity strategist and portfolio manager focused on small- and mid-cap growth and value opportunities in North American markets. Scott L. Comeau leads research-driven active equity portfolios with emphasis on fundamental analysis, thematic stock selection and risk-managed position sizing. Prior experience spans sell-side research, institutional portfolio management and public company advisory roles; known for integrating macro insights with bottom-up stock picking. Works with institutional clients on portfolio construction and performance attribution.
Veteran equity strategist and portfolio manager focused on small- and mid-cap growth and value opportunities in North American markets. Scott L. Comeau leads research-driven active equity portfolios with emphasis on fundamental analysis, thematic stock selection and risk-managed position sizing. Prior experience spans sell-side research, institutional portfolio management and public company advisory roles; known for integrating macro insights with bottom-up stock picking. Works with institutional clients on portfolio construction and performance attribution.
Research-driven investor targeting small- and mid-cap North American equities through a blend of fundamental, thematic and macro-informed stock selection. Prefers concentrated, high-conviction positions sized by risk budget and active loss limits; balances growth and value opportunities across sectors. Emphasizes rigorous due diligence, performance attribution and portfolio construction for institutional mandates, pursuing multi-quarter to multi-year horizons while managing downside with disciplined position sizing and liquidity awareness.
Research-driven investor targeting small- and mid-cap North American equities through a blend of fundamental, thematic and macro-informed stock selection. Prefers concentrated, high-conviction positions sized by risk budget and active loss limits; balances growth and value opportunities across sectors. Emphasizes rigorous due diligence, performance attribution and portfolio construction for institutional mandates, pursuing multi-quarter to multi-year horizons while managing downside with disciplined position sizing and liquidity awareness.
| Trades 537 | Longs Won 410/537 76% | Profit Factor 55.49 |
| Profitability | Shorts Won 0/0 0% | Standard Deviation $990,913.77 |
| Average Win $191,378.4 | Best Trade (Aug 14) $20.9M | Sharpe Ratio -10.55 |
| Average Loss -$11,134.13 | Worst Trade (Aug 02) -$235,920.31 | Z-Score 17.66 (100%) |
| Commissions $0 | Avg. Trade Length 1y 2m 1w 4d | Expectancy $143,484.38 |
| Loss Size | 100% | 90% | 80% | 70% | 60% | 50% | 40% | 30% | 20% | 10% |
| Probability of Loss | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | 0.01% |
| Consecutive Losing Trades | 27,778 | 25,000 | 22,222 | 19,444 | 16,667 | 13,889 | 11,111 | 8,333 | 5,556 | 2,778 |
| Symbol | Quantity | Cost | Value | Comm. | Profit ($) | Gain (%) | Change |
|---|---|---|---|---|---|---|---|
AAPL Apple Inc. | 1,086 | $281,225.34 | $335,476.26 | - | $54,250.92 | 19.29% | -7.354% |
ABBV AbbVie Inc. | 5,134 | $811,951.75 | $1.29M | - | $476,374.21 | 58.67% | -2.513% |
ABT Abbott Laboratories | 4,775 | $530,470.71 | $504,717.5 | - | -$25,753.21 | -4.85% | +0.085% |
AMZN Amazon.com Inc | 1,293 | $237,635.86 | $351,152.93 | - | $113,517.07 | 47.77% | +15.321% |
BAI iShares A.I. Innovation and Tech Active ETF | 37,305 | $1.27M | $1.54M | - | $274,120.93 | 21.62% | +0.633% |
BAX Baxter International Inc. | 21,156 | $803,904.79 | $553,440.96 | - | -$250,463.83 | -31.16% | -2.206% |
BINC iShares Flexible Income Active ETF | 7,944 | $416,378.73 | $413,008.56 | - | -$3,370.17 | -0.81% | -0.077% |
BLCR iShares Large Cap Core ACT ETF | 28,375 | $1.18M | $1.38M | - | $201,400.26 | 17.08% | +1.333% |
BND Vanguard Total Bond Market Index Fund | 5,116 | $378,875.45 | $369,528.68 | - | -$9,346.77 | -2.47% | -0.262% |
BX Blackstone Inc. | 3,095 | $462,950.1 | $395,386.25 | - | -$67,563.85 | -14.59% | -0.25% |
CVS CVS Health Corporation | 7,753 | $610,530.51 | $809,645.79 | - | $199,115.28 | 32.61% | -0.751% |
DFAC Dimensional U.S. Core Equity 2 ETF | 3.03M | $97.99M | $134.94M | - | $36.95M | 37.71% | +0.361% |
DFAR Dimensional US Real Estate ETF | 177,401 | $4.15M | $4.75M | - | $604,546.05 | 14.57% | -0.52% |
DFCF Dimensional Core Fixed Income ETF | 285,657 | $12.09M | $11.85M | - | -$234,489.38 | -1.94% | -0.288% |
DFEM Dimensional Emerging Markets Core Equity 2 ETF | 324,106 | $8.68M | $12.22M | - | $3.54M | 40.73% | +0.426% |
DFIC Dimensional International Core Equity Market ETF | 1.12M | $30.91M | $42.82M | - | $11.91M | 38.54% | -0.574% |
DFIP Dimensional Inflation-Protected Securities ETF | 127,636 | $5.25M | $5.17M | - | -$84,682.22 | -1.61% | -0.111% |
DFSD Dimensional Short-Duration Fixed Income ETF | 404,463 | $19.16M | $19.14M | - | -$26,460.17 | -0.14% | -0.063% |
DGRO iShares Core Dividend Growth ETF | 5,278 | $313,831.66 | $411,736.79 | - | $97,905.13 | 31.2% | -0.281% |
DSTL Distillate U.S. Fundamental Stability & Value ETF | 5,136 | $254,284.29 | $334,867.2 | - | $80,582.91 | 31.69% | -0.367% |